Gimv
Gimv promotes Laga to chair
Appointment marks the end of Gimv’s five-year transition into platform-based investments
Boosting returns by reducing carbon emissions
This second instalment in our investigation of PE and the green economy looks at reducing emissions in existing investments
Gimv’s Vandeurzen to step down in June as part of succession
Resignation marks the end of the GP’s five-year transition into investing via four platforms
Gimv buys Itho Daalderop and Klimaatgarant for merger
Group is latest business to enter Gimv’s Sustainable Cities programme
Gimv acquires minority stake in Legallais
Ironmongery distributor Legallais reported a turnover of €225m for 2015
Gimv buys 75% stake in Brakel
GP invests in the Dutch natural climate control business via its balance sheet
Deal in Focus: Bencis and Gimv ink trade sale for Xeikon
An in-depth look at Bencis and Gimv's trade sale of Xeikon
Competitive 2016 ahead for booming Benelux
A look back on PE activity in Benelux reveals a competitive year ahead for the region
Bencis and Gimv to sell Xeikon to Flint
Trade sale follows €168m take-private in July 2013
Nordic PE healthcare deals in need of resuscitation
Dwindling healthcare dealflow belies the Nordic region's strong fundamentals
Gimv injects €12.5m into Zorgbedrijven
GP to secure minority stake in clinic operator
Gimv et al. in €31.3m series-C for Biom’up
Round comes three years after €6.8m series-B
Gimv et al. invest €2m in CoScale
CoScale focuses on speeding up slow websites
Gimv’s Almaviva buys Arago and Domus
Bolt-on is the latest in a series by the business since inception
Gimv and Siparex in partial EasyVoyage exit
Divestment understood to be finalised within next 36 months
Gimv exits Prosonix in £100m trade sale
Trade sale comes three years after Gimv's £5.7m investment
Gimv sells off Acertys divisions
Deal marks first exit from Gimv's Health & Care platform
Gimv to sell XL Video to PRG
Deal expected to go forward in June
Gimv acquires United Dutch Breweries
Former owner Egeria had held the company since 2011
Gimv et al. sell ActoGenix for $60m
Transaction includes $30m worth of Intrexon stock
Gimv exits Viabuild
Sale of 30% stake results in a €2.3m net capital gain for GP
Benelux activity strengthens despite controversies
From LuxLeaks to a $250m funding round – Benelux experienced a varied year
Gimv’s Almaviva bolts on Paris hospital
Bolt-on increases Almaviva's 2014 revenues to €130m
Gimv et al. invest €12m in Teads
Company is potentially planning a listing on Nasdaq this year